Treatment of fertility disturbances in the male with a combination of mesterolone and kallikrein
Abstract
73 males with different fertility disturbances (53 X oligozoospermia, 4 X asthenozoospermia and 16 X teratozoospermia) were treated by a combination of mesterolone (50 mg daily) and kallikrein (6 X 100 KU daily; every two hours one tablet); duration of treatment: three months. Before starting the treatment two semen analyses were performed; furthermore semen control at the end of the treatment as well as three and six months after ending the therapy. The sperm density don't demonstrate any changes. The normal morphology of the spermatozoa increased about 10%. In selected cases with a very bad sperm morphology a testicular biopsy were performed; in these cases the percentage of normal spermatozoa increased for about 21%. The motility rate showed no significant changes. It can be demonstrated that this combination don't better effects than other treatment. The best way is a treatment at a well selected material with a special drug for a special case.
Read the paper
Related studies
- Evolution of testosterone treatment over 25 years: symptom responses, endocrine profiles and cardiovascular changes
- Vertebrate hormones influence on the reproduction of Biomphalaria glabrata and on Schistosoma mansoni infection (author's transl)
- Azoospermia associated with a mutation in the ligand-binding domain of an androgen receptor displaying normal ligand binding, but defective trans-activation
- Successful treatment of methimazole-induced severe aplastic anaemia in a diabetic patient with other co-morbidities
- The management of male subfertility by in vitro fertilisation techniques
- Rapid determination of anti-estrogens by gas chromatography/mass spectrometry in urine: Method validation and application to real samples
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.